BlossomHill Therapeutics, Inc.(BLSM:US)
Market Cap$405.39M
Key Metrics
Price$13.94
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$116M
Total Assets$143.41M
Net Assets-$152.12M
Total Debt$23.02M
Key Metrics
Price$13.94
Revenue (TTM)-
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-
EBITDA (TTM)-
Op. Margin (TTM)-
Dividend Yield-
Holders Yield-
Cash on hand$116M
Total Assets$143.41M
Net Assets-$152.12M
Total Debt$23.02M
Financials
| Name | Mar 31, 2026 | Mar 31, 2025 |
|---|---|---|
Revenue | $0 | $0 |
Cost of Revenue | - | - |
Gross Profit | - | - |
| $22.11M | $11.45M | |
| Research and Development | $19.9M | $9.57M |
| Selling, General, and Administrative | $2.21M | $1.88M |
| Other Operating Expenses | - | - |
Operating Income | -$22.11M | -$11.45M |
| $1.1M | $976K | |
| Non-Operating Interest Income | $1.1M | $976K |
| Non-Operating Interest Expense | - | - |
| Other Income/Expense | -$3K | - |
Income Before Tax | -$21.01M | -$10.48M |
Income Tax | - | - |
Net Income | -$21.01M | -$10.48M |
Minority Interests | - | - |
Preferred Stock Dividends | - | - |
Net Income to Common | -$21.01M | -$10.48M |
Shares Outstanding (Basic) | 29.08M | 29.08M |
Shares Outstanding (Diluted) | 29.08M | 29.08M |
EPS (Basic) | -$0.72 | -$0.36 |
EPS (Diluted) | -$0.72 | -$0.36 |
EBIT | -$22.11M | -$11.45M |
EBITDA | -$21.98M | -$11.37M |